On Wednesday shares of Aratana Therapeutics, Inc. (NASDAQ:PETX) closed at $12.84. Company’s EPS growth for next 5 years is recorded as 15.00%. On May 04, Traverse Biosciences announced that it has executed a $250,000 cooperative research and development agreement (CRADA) with Aratana Therapeutics Inc. (NASDAQ:PETX) to advance the development of TRB-N0224 for the treatment and control of periodontal disease in companion animals, including dogs and cats.
Smith Micro Software Inc. (NASDAQ:SMSI) in last trading activity decreased -4.17% to close at $1.15. Company weekly performance is -10.16% while its quarterly performance stands at -26.75%. Smith Micro Software Inc. (NASDAQ:SMSI) is -37.84% away from its 52 week high. On April 28, Smith Micro Software, Inc. (NASDAQ:SMSI), reported financial results for its first quarter ended March 31, 2015. Smith Micro Software reported revenue of $10.5 million for the first quarter ended March 31, 2015, compared to $8.4 million reported in the first quarter of 2014. First quarter gross profit on a GAAP and non-GAAP (which excludes stock compensation) basis was $8.4 million, compared to $6.0 million reported in the first quarter of 2014.
On last trading day RXi Pharmaceuticals Corporation (NASDAQ:RXII) decreased -6.24% to close at $0.62. Its volatility for the week is 8.96% while volatility for the month is 8.37%. RXi Pharmaceuticals Corporation (NASDAQ:RXII) monthly performance is -12.00%. RXi Pharmaceuticals Corp (NASDAQ:RXII)‘s stock had its “buy” rating restated by Zacks in a note issued to investors on Friday. They currently have a $0.75 target price on the stock. Zacks‘s target price suggests a potential upside of 11.94% from the company’s current price.
OmniVision Technologies, Inc. (NASDAQ:OVTI) has 0.90% insider ownership while its institutional ownership stands at 67.70%. In last trading activity company’s stock closed at $27.18. Announced May 4, that the fairness of the proposed acquisition of OmniVision Technologies, Inc. (NASDAQ:OVTI) by a consortium of private equity investors based in China is being investigated by WeissLaw LLP, a national class action, shareholder rights law firm. The investigation focuses on possible breaches of fiduciary duty and other violations of law by the Board of Directors of OVTI for agreeing to sell the Company to the Consortium. On April 30, 2015, the Company announced a definitive agreement for the Consortium to acquire OVTI in a transaction valued at $1.9 billion. Under the terms of the agreement, OVTI shareholders will receive $29.75 in cash for each OVTI share they own.
On last trading day Gray Television, Inc. (NYSE:GTN) decreased -2.32% to close at $13.88. Its volatility for the week is 4.89% while volatility for the month is 3.48%. GTN’s sales growth for past 5 years was 13.40% and its EPS growth for past 5 years was 24.50%. Gray Television, Inc. (NYSE:GTN) monthly performance is 0.14%. Gray Television Inc. (NYSE:GTN) on Tuesday reported first-quarter net income of $5.6 million. On a per-share basis, the Atlanta-based company said it had profit of 10 cents.